443 related articles for article (PubMed ID: 28264599)
21. Comparison of the efficacy and safety of using 0.01% versus 0.03% bimatoprost for the treatment of eyebrow hypotrichosis: A randomized, double-blind, split-face, comparative study.
Suchonwanit P; Harnchoowong S; Chanasumon N; Sriphojanart T
J Cosmet Dermatol; 2020 Mar; 19(3):714-719. PubMed ID: 31317662
[TBL] [Abstract][Full Text] [Related]
22. Acquired causes of eyebrow and eyelash loss: A review and approach to diagnosis and treatment.
Mumford BP; Eisman S; Yip L
Australas J Dermatol; 2023 Feb; 64(1):28-40. PubMed ID: 36320026
[TBL] [Abstract][Full Text] [Related]
23. Eyebrow growth pattern analysis in patients with eyebrow hypotrichosis after receiving topical treatment: A retrospective study.
Suchonwanit P; Thammarucha S
J Cosmet Dermatol; 2020 Jun; 19(6):1404-1408. PubMed ID: 31541563
[TBL] [Abstract][Full Text] [Related]
24. An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects.
Borchert M; Bruce S; Wirta D; Yoelin SG; Lee S; Mao C; VanDenburgh A
Clin Ophthalmol; 2016; 10():419-29. PubMed ID: 27022239
[TBL] [Abstract][Full Text] [Related]
25. Effects of LATISSE (bimatoprost 0.03 per cent topical solution) on the ocular surface.
Bitton E; Courey C; Giancola P; Diaconu V; Wise J; Wittich W
Clin Exp Optom; 2017 Nov; 100(6):583-589. PubMed ID: 28122407
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows.
Faghihi G; Andalib F; Asilian A
Eur J Dermatol; 2009; 19(6):586-7. PubMed ID: 19620039
[TBL] [Abstract][Full Text] [Related]
27. Promising alternative clinical uses of prostaglandin F2α analogs: beyond the eyelashes.
Choi YM; Diehl J; Levins PC
J Am Acad Dermatol; 2015 Apr; 72(4):712-6. PubMed ID: 25601618
[TBL] [Abstract][Full Text] [Related]
28. Hypertrichosis of the eyelashes caused by bimatoprost.
Tosti A; Pazzaglia M; Voudouris S; Tosti G
J Am Acad Dermatol; 2004 Nov; 51(5 Suppl):S149-50. PubMed ID: 15577756
[TBL] [Abstract][Full Text] [Related]
29. Retrospective Evaluation of Topical Bimatoprost and Iris Pigmentation Change.
Zaleski-Larsen LA; Ruth NH; Fabi SG
Dermatol Surg; 2017 Dec; 43(12):1431-1433. PubMed ID: 28562438
[TBL] [Abstract][Full Text] [Related]
30. Bimatoprost versus Mometasone Furoate in the Treatment of Scalp Alopecia Areata: A Pilot Study.
Zaher H; Gawdat HI; Hegazy RA; Hassan M
Dermatology; 2015; 230(4):308-13. PubMed ID: 25765294
[TBL] [Abstract][Full Text] [Related]
31. Recent progress in prostaglandin F2α ethanolamide (prostamide F2α) research and therapeutics.
Woodward DF; Wang JW; Poloso NJ
Pharmacol Rev; 2013; 65(4):1135-47. PubMed ID: 23893067
[TBL] [Abstract][Full Text] [Related]
32. A retrospective review and observational study of outcomes and safety of bimatoprost ophthalmic solution 0.03% for treating eyelash hypotrichosis.
Yoelin SG; Fagien S; Cox SE; Davis PG; Campo A; Caulkins CA; Gallagher CJ
Dermatol Surg; 2014 Oct; 40(10):1118-24. PubMed ID: 25229783
[TBL] [Abstract][Full Text] [Related]
33. Hair transplantation to the eyebrow, eyelashes, and other parts of the body.
Gandelman M; Epstein JS
Facial Plast Surg Clin North Am; 2004 May; 12(2):253-61. PubMed ID: 15135136
[TBL] [Abstract][Full Text] [Related]
34. Enhanced eyelashes: prescription and over-the-counter options.
Jones D
Aesthetic Plast Surg; 2011 Feb; 35(1):116-21. PubMed ID: 20730536
[TBL] [Abstract][Full Text] [Related]
35. Successful Treatment of Pediatric Alopecia Areata of the Scalp Using Topical Bimatoprost.
Li AW; Antaya RJ
Pediatr Dermatol; 2016 Sep; 33(5):e282-3. PubMed ID: 27377163
[TBL] [Abstract][Full Text] [Related]
36. Hair transplantation for therapy-resistant alopecia areata of the eyebrows: is it the right choice?
Civaş E; Aksoy B; Aksoy HM; Eski M; Yucel K
J Dermatol; 2010 Sep; 37(9):823-6. PubMed ID: 20883369
[TBL] [Abstract][Full Text] [Related]
37. [ON A FAMILY WITH THE RECESSIVE TRAIT OF WOOLLY HAIR, HYPOTRICHOSIS AND OTHER ANOMALIES].
SALAMON T
Hautarzt; 1963 Dec; 14():540-4. PubMed ID: 14113527
[No Abstract] [Full Text] [Related]
38. Isolated eyebrow and eyelash trichotillomania mimicking alopecia areata.
Radmanesh M; Shafiei S; Naderi AH
Int J Dermatol; 2006 May; 45(5):557-60. PubMed ID: 16700791
[TBL] [Abstract][Full Text] [Related]
39. Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata.
Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes FP; Dutronc Y; Mesinkovska N; Ko JM; King BA
Am J Clin Dermatol; 2020 Oct; 21(5):725-732. PubMed ID: 32803546
[TBL] [Abstract][Full Text] [Related]
40. The value of dermoscopy in diagnosing eyebrow loss in patients with alopecia areata and frontal fibrosing alopecia.
Waśkiel-Burnat A; Rakowska A; Kurzeja M; Czuwara J; Sikora M; Olszewska M; Rudnicka L
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):213-219. PubMed ID: 30290016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
